NuGen Medical Devices Inc.
NGMD.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.20K | 16.00K | 81.40K | 297.00K | 389.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.20K | 16.00K | 81.40K | 297.00K | 389.90K |
| Cost of Revenue | 9.80K | 6.40K | 36.40K | 136.30K | 198.20K |
| Gross Profit | 15.30K | 9.60K | 45.00K | 160.70K | 191.70K |
| SG&A Expenses | 882.60K | 608.80K | 520.50K | 667.80K | 1.64M |
| Depreciation & Amortization | -- | 118.40K | 109.80K | 113.00K | 114.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 892.40K | 733.60K | 666.80K | 917.00K | 1.95M |
| Operating Income | -867.20K | -717.60K | -585.30K | -620.00K | -1.56M |
| Income Before Tax | -1.36M | -1.68M | 1.09M | 361.70K | -2.16M |
| Income Tax Expenses | -3.30K | 3.00K | 2.70K | -2.80K | 7.90K |
| Earnings from Continuing Operations | -1.36M | -1.68M | 1.09M | 364.50K | -2.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.36M | -1.68M | 1.09M | 364.50K | -2.17M |
| EBIT | -867.20K | -717.60K | -585.30K | -620.00K | -1.56M |
| EBITDA | -744.10K | -599.20K | -475.50K | -507.00K | -1.45M |
| EPS Basic | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 227.04M | 227.04M | 226.47M | 219.46M | 217.32M |
| Average Diluted Shares Outstanding | 227.04M | 227.04M | 226.47M | 219.46M | 217.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |